Ontology highlight
ABSTRACT: Importance
Bone marrow or peripheral blood from unrelated donors may be used for hematopoietic cell transplantation. Information about the relative success of transplantation with these 2 graft sources would help physicians and patients choose between them.Objective
To compare patient-reported outcomes between patients randomized to receive 1 of 2 graft types for unrelated donor transplantation.Design, setting, and participants
This follow-up of a randomized clinical trial included English- or Spanish-speaking patients 16 years or older participating in a multicenter randomized clinical trial of unrelated donor bone marrow (BM) vs peripheral blood (PB) (N = 551) in hematopoietic cell transplantation for hematologic neoplasms. Patient-reported outcomes were collected
SUBMITTER: Lee SJ
PROVIDER: S-EPMC5145732 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature